Committee for Medicinal Products for Veterinary Use (CVMP): 16-18 April 2024, European Medicines Agency, Amsterdam, the Netherlands, from 16 April 2024 to 18 April 2024

Committee for Medicinal Products for Veterinary Use (CVMP): 16-18 April 2024, European Medicines Agency, Amsterdam, the Netherlands, from 16 April 2024 to 18 April 2024

SPOR Status Update, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 10 April 2024, 10:00 (CEST) to 10 April 2024, 12:30 (CEST)

SPOR Status Update, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 10 April 2024, 10:00 (CEST) to 10 April 2024, 12:30 (CEST)

Human medicines European public assessment report (EPAR): Sifrol, pramipexole, Date of authorisation: 13/10/1997, Revision: 39, Status: Authorised

Human medicines European public assessment report (EPAR): Sifrol, pramipexole, Date of authorisation: 13/10/1997, Revision: 39, Status: Authorised

Human medicines European public assessment report (EPAR): Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune), pandemic influenza vaccine (H5N1) (live attenuated, nasal), Date of authorisation: 20/05/2016, Re

Human medicines European public assessment report (EPAR): Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune), pandemic influenza vaccine (H5N1) (live attenuated, nasal), Date of authorisation: 20/05/2016, Revision: 10, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness